Skip to content

Macerich MAC Gain (Loss) on Sale of Assets and Asset Impairment Charges

Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies

Las Vegas Sands logo
Las Vegas SandsLVS

Other financials

Income statement

See full
Revenue$241.5M-3.1%
Net income-$36.4M+27.5%
EPS (diluted)-$0.14+30.0%

Balance sheet

See full
Cash & equivalents$182.0M-28.1%
Total debt$65.1M-0.5%
Total equity$2.4B-8.5%
Total assets$8.2B-5.6%

Cash flow

See full
Operating cash flow$77.4M-12.6%

Valuation

See full
Market cap$7.03B+11.9%
Enterprise value$6.91B+14.1%
P/S+0.4×

Profitability

See full
Net margin-18.2%+17.3pp

Returns & leverage

See full
Return on equity-7.2%+7.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Macerich in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.

The official record: Macerich’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Macerich's gain (loss) on sale of assets and asset impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Macerich's gain (loss) on sale of assets and asset impairment charges?
Macerich (MAC) reported gain (loss) on sale of assets and asset impairment charges of $6.84M in Q1 2026.
How has Macerich's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
Macerich's gain (loss) on sale of assets and asset impairment charges increased by 148.9% year-over-year, from -$13.99M to $6.84M.
What is the long-term trend for Macerich's gain (loss) on sale of assets and asset impairment charges?
Over 2 years (2022 to 2025), Macerich's gain (loss) on sale of assets and asset impairment charges has grown at a 300.4% compound annual growth rate (CAGR), from $7.7M to -$123.42M.
What does gain (loss) on sale of assets and asset impairment charges mean?
This reflects the net financial impact of disposing of real estate assets or recognizing write-downs due to changes in market value or asset utility. It provides insight into the company's portfolio optimization strategy and the long-term valuation health of its holdings.